Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05958030
NA

GyroGlove Use in Essential Tremor Patients

Sponsor: GyroGear Ltd

View on ClinicalTrials.gov

Summary

This is a multi-centre, single-blind, placebo-controlled trial with an open label follow up. After the baseline assessment, all participants will receive the GyroGlove for two weeks during the open label follow up part of the trial. All gloves will be retrieved and returned to GyroGear after closure of the study.

Official title: Effectiveness and Safety of GyroGlove in Stabilising Hand Tremors in Essential Tremor

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-07

Completion Date

2025-12

Last Updated

2025-03-14

Healthy Volunteers

No

Interventions

DEVICE

Placebo

The placebo device consists of the same hardware as GyroGlove: aesthetically it looks the same, weight same and produces the same noise as GyroGlove. Participants will interact with Placebo on the day of baseline visit (i.e. Day 0).

DEVICE

GyroGlove

GyroGlove is a patented wearable device containing high-performance, miniaturised, gyroscopes designed for individuals diagnosed with essential tremor. Participants will interact with GyroGlove on the day of baseline visit (i.e. Day 0), 2-week Home use and on the day of follow-up visit (i.e Day 14).

Locations (7)

Quest Research Institute

Farmington Hills, Michigan, United States

Houston Methodist Stanley H. Appel Department of Neurology

Houston, Texas, United States

University of Vermont Medical Centre

Burlington, Vermont, United States

Addenbrooke Hospital, Cambridge University Hospital NHS Trust

Cambridge, England, United Kingdom

Clinical Ageing Research Unit, Newcastle University

Newcastle, England, United Kingdom

Oxford University Hospitals NHS Foundation Trust, UK

Oxford, England, United Kingdom

North Tyneside General Hospital

Newcastle, United Kingdom